Investing.com - Idorsia reported on Tuesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Idorsia announced earnings per share of CHF-1.22 on revenue of CHF21.03. Analysts polled by Investing.com EPS of CHF-1.21 on revenue of CHF28.43M.
Idorsia 's are down 26% and is trading at CHF13.98 , still down 36.91% from its 52 week high of CHF22.16 set on Thursday, January 20, 2022.
Idorsia follows other major Healthcare sector earnings this month
Idorsia's report follows an earnings matched by Santhera Pharmaceuticals Holding on Thursday, September 29, 2022, who reported EPS of CHF-0.2 on revenue of CHF1.7M, EPS of CHF-0.2 on revenue of CHF1.7M.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar